BR112023019249A2 - Peptídeos e métodos para reduzir a pigmentação da pele - Google Patents

Peptídeos e métodos para reduzir a pigmentação da pele

Info

Publication number
BR112023019249A2
BR112023019249A2 BR112023019249A BR112023019249A BR112023019249A2 BR 112023019249 A2 BR112023019249 A2 BR 112023019249A2 BR 112023019249 A BR112023019249 A BR 112023019249A BR 112023019249 A BR112023019249 A BR 112023019249A BR 112023019249 A2 BR112023019249 A2 BR 112023019249A2
Authority
BR
Brazil
Prior art keywords
methods
peptides
reduce
disclosure
skin pigmentation
Prior art date
Application number
BR112023019249A
Other languages
English (en)
Inventor
A Love Robert
Original Assignee
Glo Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glo Pharma Inc filed Critical Glo Pharma Inc
Publication of BR112023019249A2 publication Critical patent/BR112023019249A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)

Abstract

peptídeos e métodos para reduzir a pigmentação da pele. a presente divulgação refere-se a novos antagonistas peptídicos que inibem a ligação do hormônio estimulador de melanócitos ao receptor de melanocortina 1. os antagonistas peptídicos da divulgação são úteis em composições cosméticas que previnem ou reduzem o aparecimento de descoloração da pele causada pela pigmentação. a divulgação refere-se adicionalmente a composições cosméticas compreendendo um antagonista peptídico da divulgação e métodos para seu uso para prevenir ou reduzir o aparecimento de descoloração da pele em um indivíduo em necessidade do mesmo.
BR112023019249A 2021-03-24 2022-03-23 Peptídeos e métodos para reduzir a pigmentação da pele BR112023019249A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165611P 2021-03-24 2021-03-24
US202163271646P 2021-10-25 2021-10-25
PCT/US2022/021579 WO2022204305A2 (en) 2021-03-24 2022-03-23 Peptides and methods for reducing skin pigmentation

Publications (1)

Publication Number Publication Date
BR112023019249A2 true BR112023019249A2 (pt) 2023-12-12

Family

ID=83398134

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023019249A BR112023019249A2 (pt) 2021-03-24 2022-03-23 Peptídeos e métodos para reduzir a pigmentação da pele

Country Status (7)

Country Link
EP (1) EP4313100A2 (pt)
JP (1) JP2024511214A (pt)
KR (1) KR20240035939A (pt)
AU (1) AU2022242835A1 (pt)
BR (1) BR112023019249A2 (pt)
CA (1) CA3213099A1 (pt)
WO (1) WO2022204305A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220070246A (ko) 2019-09-23 2022-05-30 디디에스 리서치 인크. 침투 증진제를 갖는 지질 소포 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US20040219232A1 (en) * 2003-02-06 2004-11-04 Zengen, Inc. Methods and compounds for treating malabsorption diseases and inflammatory conditions of the gastrointestinal tract
DE602005021858D1 (de) * 2004-02-11 2010-07-29 Amylin Pharmaceuticals Inc Peptide der amylin familie, verfahren zu deren herstellung und verwendung
KR20180118250A (ko) * 2008-05-27 2018-10-30 젠자임 코포레이션 알파-멜라노사이트 자극 호르몬의 펩티드 유사체
KR20110112381A (ko) * 2008-12-31 2011-10-12 레반스 테라퓨틱스, 아이엔씨. 색소 과다 침착의 치료용 조성물 및 치료 방법
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
EP2654779B1 (en) * 2010-12-23 2018-02-28 Ludwig Institute for Cancer Research, Ltd. Liposomal formulation of nonglycosidic ceramides and uses thereof

Also Published As

Publication number Publication date
CA3213099A1 (en) 2022-09-29
AU2022242835A1 (en) 2023-10-05
EP4313100A2 (en) 2024-02-07
WO2022204305A3 (en) 2022-11-17
JP2024511214A (ja) 2024-03-12
WO2022204305A2 (en) 2022-09-29
KR20240035939A (ko) 2024-03-19

Similar Documents

Publication Publication Date Title
BR112023019249A2 (pt) Peptídeos e métodos para reduzir a pigmentação da pele
CA2892134C (en) Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
MY194925A (en) Composition of fish skin collagen peptides and use thereof as a drug
BRPI0517500A (pt) compostos, uso de uma composição, composição farmacêutica, composição cosmética, uso não-terapêutico de uma composição cosmética e processo cosmético para melhorar a aparência da pele
BR112021015519A2 (pt) Composto, combinação de um composto, composição, uso de um composto, e, método de tratamento e/ou cuidado cosmético não terapêutico da pele, cabelo, unhas e/ou membranas mucosas
CL2011000086A1 (es) Anticuerpo aislado o proteina funcional contra el polipeptido baffr que inhibe la proliferacion de celulas b; secuencia nucleotidicas de dicho anticuerpo; vector y celula huesped que comprende dicha secuencia; y su uso para tratar enfermedades autoinmunes o neoplasias de celulas b.
WO2012143364A3 (en) Cosmetic composition for use in increasing collagen synthesis in skin cells
MX347229B (es) Antagonistas de péptido de la familia cgrp de calcitonina de hormonas de péptido y su uso.
JP2017536375A (ja) Ｓｆｒｐ５由来ペプチド断片およびそれを含有する皮膚美白用化粧料組成物
US10987295B2 (en) Method of facilitating the bindings between keratinocytes
AR059638A1 (es) Composiciones contentivas de peptidos con aminoacidos no naturales y metodos de uso
US20200016437A1 (en) Skin Care Compositions
MX2020003563A (es) Anticuerpo anti-pacap.
WO2011126940A3 (en) Topical uses of szeto-schiller peptides
WO2018097605A3 (ko) 바다제비집 복합 발효 추출물을 유효성분으로 포함하는 피부주름 개선용 조성물, 이를 이용한 피부주름 개선용 패치, 및 마스크 팩
ES2532545T3 (es) Nuevos péptidos que intervienen en la vía de señalización de SCF c-Kit y composiciones que los comprenden
US20170136146A1 (en) Composition for maintaining efficacy of filler
BR112022020338A2 (pt) Composições peptídicas e métodos para inibir atividade do receptor nicotínico da acetilcolina
BR112018002263A2 (pt) plataforma em andaime de nó de cistina
CL2022003296A1 (es) Anticuerpos anti-cd200r1 y métodos de uso de los mismos
Ródenas‐Herranz et al. Acrylate allergic contact dermatitis caused by hair prosthesis fixative.
BR112014024192A2 (pt) epítopos de antígeno superficial do receptor de fator de crescimento epidérmico e uso desses
MX2020004257A (es) Uso cosmetico de un extracto de marfil vegetal (phytelephas sp.).
BR112022004898A2 (pt) Feromônio neonatal materno de suíno
EA201200889A1 (ru) Пептид